Market overview
The global capsule market is worth USD 3.4 bn in 2026 and is forecast to reach USD 6.4 bn by 2036, growing at a 6.5% CAGR. United States is the largest country market and Gelatin is the largest by material segment.
| Scope | Empty hard capsule shells made of gelatin, HPMC and pullulan, supplied to pharmaceutical, nutraceutical and supplement manufacturers for filling. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 3.2 bn |
| Value 2026 | USD 3.4 bn |
| Value 2036 | USD 6.4 bn |
| CAGR 2026-2036 | 6.5% |
| Volume 2026 | 1,218,657 million pieces |
| Volume 2036 | 2,176,290 million pieces |
| Average price 2026 | USD 0.00 per piece |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Capsule market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 3.4 bn |
| 2027 | USD 3.6 bn |
| 2028 | USD 3.9 bn |
| 2029 | USD 4.1 bn |
| 2030 | USD 4.4 bn |
| 2031 | USD 4.7 bn |
| 2032 | USD 5.0 bn |
| 2033 | USD 5.3 bn |
| 2034 | USD 5.6 bn |
| 2035 | USD 6.0 bn |
| 2036 | USD 6.4 bn |
Capsule market segmentation
By material
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Gelatin | 68.0% | 55.6% | USD 2.3 bn | 4.4% |
| HPMC and plant-based | 28.0% | 38.2% | USD 954 mn | 9.8% |
| Pullulan and other | 4.0% | 6.2% | USD 136 mn | 11.3% |
By end use
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Pharmaceuticals | 48.0% | 45.9% | USD 1.6 bn | 6.0% |
| Dietary supplements and nutraceuticals | 40.0% | 42.0% | USD 1.4 bn | 7.0% |
| Cosmetics and other | 12.0% | 12.0% | USD 409 mn | 6.5% |
By capsule type
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Hard gelatin capsules | 50.0% | 44.0% | USD 1.7 bn | 5.2% |
| Hard vegetarian capsules | 14.0% | 16.0% | USD 477 mn | 7.9% |
| Soft capsules | 36.0% | 40.0% | USD 1.2 bn | 7.6% |
By source
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Bovine gelatin | 34.0% | 28.0% | USD 1.2 bn | 4.5% |
| Porcine and fish gelatin | 26.0% | 24.0% | USD 886 mn | 5.7% |
| Plant-based | 40.0% | 48.0% | USD 1.4 bn | 8.5% |
By therapeutic area
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Dietary supplements | 42.0% | 44.0% | USD 1.4 bn | 7.0% |
| Pain relief | 16.0% | 14.0% | USD 545 mn | 5.1% |
| Cardiovascular | 12.0% | 12.0% | USD 409 mn | 6.5% |
| Gastrointestinal | 12.0% | 12.0% | USD 409 mn | 6.5% |
| Other areas | 18.0% | 18.0% | USD 613 mn | 6.5% |
Top 25 countries for capsule by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 79.0% of 2026 revenue and the 25 countries below together hold 95.4%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 750 mn | 22.0% | USD 1.3 bn | 5.3% |
| 2 | China | USD 545 mn | 16.0% | USD 1.2 bn | 8.3% |
| 3 | India | USD 375 mn | 11.0% | USD 915 mn | 9.3% |
| 4 | Germany | USD 204 mn | 6.0% | USD 326 mn | 4.8% |
| 5 | Japan | USD 204 mn | 6.0% | USD 301 mn | 3.9% |
| 6 | Brazil | USD 153 mn | 4.5% | USD 294 mn | 6.7% |
| 7 | United Kingdom | USD 136 mn | 4.0% | USD 218 mn | 4.8% |
| 8 | France | USD 119 mn | 3.5% | USD 192 mn | 4.9% |
| 9 | Italy | USD 102 mn | 3.0% | USD 166 mn | 5.0% |
| 10 | South Korea | USD 102 mn | 3.0% | USD 179 mn | 5.8% |
| 11 | Mexico | USD 86 mn | 2.5% | USD 170 mn | 7.0% |
| 12 | Russia | USD 65 mn | 1.9% | USD 128 mn | 7.0% |
| 13 | Switzerland | USD 62 mn | 1.8% | USD 108 mn | 5.7% |
| 14 | Spain | USD 50 mn | 1.5% | USD 88 mn | 5.8% |
| 15 | Netherlands | USD 48 mn | 1.4% | USD 84 mn | 5.7% |
| 16 | Turkey | USD 46 mn | 1.3% | USD 90 mn | 7.0% |
| 17 | Thailand | USD 34 mn | 1.0% | USD 67 mn | 6.9% |
| 18 | Poland | USD 33 mn | 1.0% | USD 64 mn | 6.9% |
| 19 | Belgium | USD 27 mn | 0.8% | USD 47 mn | 5.8% |
| 20 | Argentina | USD 22 mn | 0.7% | USD 44 mn | 7.0% |
| 21 | Australia | USD 21 mn | 0.6% | USD 38 mn | 5.8% |
| 22 | Canada | USD 21 mn | 0.6% | USD 37 mn | 5.8% |
| 23 | Vietnam | USD 16 mn | 0.5% | USD 31 mn | 6.9% |
| 24 | Bangladesh | USD 13 mn | 0.4% | USD 26 mn | 7.0% |
| 25 | Pakistan | USD 13 mn | 0.4% | USD 25 mn | 6.8% |
| Rest of world | USD 157 mn | 4.6% | USD 285 mn | 6.1% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Lonza
- ACG
- Qualicaps
Group 2: Regional and specialist players
- Suheung
- Roxlor
- Sunil Healthcare
- Capsuline
- Farmacapsulas
- Erawat Pharma
- Natural Capsules
- Shaoxing Kangke Capsule
Group 3: Emerging and niche players
- CapsCanada
- Medi-Caps
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the capsule market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 6.5% is calculated from the resulting values.
The market is divided by material, by end use, by capsule type, by source, by therapeutic area. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the capsule market?
The global capsule market is estimated at USD 3.2 bn in 2025 and USD 3.4 bn in 2026.
How fast will the capsule market grow?
It is forecast to reach USD 6.4 bn by 2036, a compound annual growth rate of 6.5% from 2026, an increase of USD 3.0 bn.
Which country is the largest market for capsule?
United States is the largest market by revenue at USD 750 mn in 2026, 22.0% of the global total. The three largest countries together hold 49.0%.
Which country is growing fastest?
Among the ten largest markets, India is growing fastest at 9.3% a year from 2026 to 2036.
Which capsule segment is largest?
In the by material split, Gelatin is the largest segment with 68.0% of 2026 revenue.
Who are the leading capsule companies?
Global leaders include Lonza, ACG, Qualicaps.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Neurorehabilitation TechnologyUSD 3.4 bn · 9.0% CAGR
- Healthcare Provider Workflow OptimizationUSD 3.4 bn · 10.5% CAGR
- ImmunohistochemistryUSD 3.5 bn · 8.0% CAGR
- BiobankingUSD 3.2 bn · 8.5% CAGR
- AutoinjectorUSD 3.7 bn · 10.0% CAGR
- Pharmaceutical SerializationUSD 3.7 bn · 9.0% CAGR
- Lyophilization EquipmentUSD 3.1 bn · 7.6% CAGR
- Continuous Positive Airway Pressure (CPAP)USD 3.1 bn · 6.5% CAGR
← Capsule Filling Machine Carboxylate-Modified Magnetic Beads →